De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado‐Castellarnau, P de Atauri… - Molecular systems …, 2017 - embopress.org
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …
被引用次数：60 相关文章

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado‐Castellarnau, P Atauri, J Tarragó‐Celada… - 2017 - digital.csic.es
Cyclin-dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …
[HTML] nih.gov

[HTML][HTML] De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado‐Castellarnau, P de Atauri… - Molecular Systems …, 2017 - ncbi.nlm.nih.gov
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition.

M Tarrado-Castellarnau, P de Atauri… - Molecular Systems …, 2017 - europepmc.org
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …
[PDF] academia.edu

[PDF][PDF] De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado-Castellarnau, P de Atauri… - Molecular Systems …, 2017 - academia.edu
Cyclin-dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …
[PDF] figshare.com

[PDF][PDF] De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado-Castellarnau, P de Atauri, J Tarragó-Celada… - 2017 - crick.figshare.com
Cyclin-dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …
[HTML] embopress.org

[HTML][HTML] De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado‐Castellarnau, P de Atauri… - Molecular Systems …, 2017 - embopress.org
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

MN Tarrado Castellarnau, R Atauri Carulla… - … Systems Biology, 2017 …, 2017 - diposit.ub.edu
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition

M Tarrado-Castellarnau, P de Atauri… - Molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
Cyclin-dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …

De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition.

M Tarrado-Castellarnau, P de Atauri… - Molecular Systems …, 2017 - europepmc.org
Cyclin‐dependent kinases (CDK) are rational cancer therapeutic targets fraught with the
development of acquired resistance by tumor cells. Through metabolic and transcriptomic …